Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2021-03-04 BALDO LANCE Chief Medical Officer Grant or award · Stock Option (Right to Buy) +57,234 57,234
2021-03-04 RUBINSTEIN JULIE President Grant or award +45,788 45,788
2021-03-04 RUBINSTEIN JULIE President Grant or award · Stock Option (Right to Buy) +114,469 114,469
2021-03-04 Taylor Stacy L SVP and General Counsel Grant or award +13,736 15,036
2021-03-04 Taylor Stacy L SVP and General Counsel Grant or award · Stock Option (Right to Buy) +34,341 34,341
2021-03-04 BENZENO SHARON Chief Business Development Off Grant or award +22,894 22,894
2021-03-04 BENZENO SHARON Chief Business Development Off Grant or award · Stock Option (Right to Buy) +57,234 57,234
2021-03-04 ADAMS R MARK EVP & Chief Operating Officer Grant or award +20,604 70,604
2021-03-04 ADAMS R MARK EVP & Chief Operating Officer Grant or award · Stock Option (Right to Buy) +51,511 51,511
2021-03-04 ROBINS CHAD M CEO and Chairman Grant or award +68,681 1,778,461
2021-03-04 ROBINS CHAD M CEO and Chairman Grant or award · Stock Option (Right to Buy) +171,703 171,703
2021-03-04 LO FRANCIS Chief People Officer Grant or award +20,604 20,604
2021-03-04 LO FRANCIS Chief People Officer Grant or award · Stock Option (Right to Buy) +51,511 51,511
2021-03-04 Cohen Chad M Chief Financial Officer Grant or award +20,604 21,604
2021-03-04 Cohen Chad M Chief Financial Officer Grant or award · Stock Option (Right to Buy) +51,511 51,511
2021-03-04 BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ Grant or award +9,158 9,158
2021-03-04 BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ Grant or award · Stock Option (Right to Buy) +22,894 22,894
2021-03-01 Pellini Michael J Director Option exercise +20,000 $6.55 $131K 21,504
2021-03-01 Pellini Michael J Director Sale −20,000 $57.80 $1.2M 1,504
2021-03-01 Pellini Michael J Director Option exercise · Stock Option (Right to Buy) −20,000 55,000

Page 55 of 120 · 2,386 trades